(OKLAHOMA CITY) — Scientists at the Oklahoma Medical Research Foundation (OMRF) have announced the discovery of a new interferon-like substance they named “limitin” because of its ability to limit tumor cell growth. Limitin is partially similar in structure to the type I interferons, naturally occurring proteins first discovered for their ability to curtail viral replication. […]
OMRF Researchers Discover Limitin A new interferon-like substance
Federal Judges Get Hands-On Lesson in DNA Trading the Judicial Bench for the Laboratory Bench, Judges Take Course in DNA Technology
(OKLAHOMA CITY) — Federal judges met to discuss DNA technology today, but instead of wearing their traditional black robes, these judges donned white lab coats. The judges participated in the Oklahoma Medical Research Foundation’s workshop called “Forensic Genetics: A Laboratory Course in Molecular Fingerprinting,” which is a hands-on seminar in DNA technology. This is the […]
Tang Receives Brumback Award for Excellence in Research
(OKLAHOMA CITY) — Today, Jordan Tang, Ph.D., was presented the Brumback Excellence in Research Award by the Alzheimer’s Association of Oklahoma, Central Oklahoma Branch. Dr. Tang is the J.G. Puterbaugh Chair in Biomedical Research and Head of the Protein Studies Program at the Oklahoma Medical Research Foundation. The award was presented during the Alzheimer’s Association’s […]
Oklahoma Researchers Develop Inhibitor for Alzheimer’s Disease Enzyme
Oklahoma City, OK – Researchers at the Oklahoma Medical Research Foundation (OMRF) have successfully designed a highly potent inhibitor for Memapsin 2, the enzyme believed to be directly responsible for Alzheimer’s disease. The same team of scientists at OMRF, led by Jordan Tang, Ph.D., identified and produced Memapsin 2 earlier this year. This study was […]
CALENDAR OF CAMPAIGN EVENTS
CALENDAR OF CAMPAIGN EVENTS March 31, 2000 Finance and Audit Committee Meeting April 3, 2000 Investment Committee Meeting April 3, 2000 Executive Committee Meeting April 6, 2000 Nominating/Honors & Awards Meeting April 11, 2000 Board of Directors Meeting at 6:00 p.m. June 19, 2000 Building Dedication
PROGRESS TOWARD CAMPAIGN GOALS AS OF APRIL 1, 2000
PROGRESS TOWARD CAMPAIGN GOALS AS OF APRIL 1, 2000 Goal Acheived Endowment Needs $66,000,000 $27,906,116 Capital Project Needs $34,000,000 $21,826,525 Total $100,000,000 $49,732,641 PROPOSALS SUBMITTED AND STATUS PENDING $5,000,000 Vivarium $1,000,000 Endowment & Capital $500,000 Endowment $500,000 Endowment $250,000 Capital Project $190,000 Capital Project […]
